Furthermore, although we confirmed the finding that ruscogenin inhibits pyroptosis and thereby alleviates colitis through the TLR4/NF-κB pathway, transgenic mouse experiments are necessary to verify this pathway before using ruscogenin in IBD patients. This evidence concerns the gene NFKB1 and colitis.